Sandra de Bie

433 total citations
16 papers, 271 citations indexed

About

Sandra de Bie is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Sandra de Bie has authored 16 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Toxicology, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Epidemiology. Recurrent topics in Sandra de Bie's work include Pharmacovigilance and Adverse Drug Reactions (7 papers), Pharmaceutical studies and practices (6 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Sandra de Bie is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (7 papers), Pharmaceutical studies and practices (6 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Sandra de Bie collaborates with scholars based in Netherlands, Italy and United States. Sandra de Bie's co-authors include Miriam Sturkenboom, Sabine M. J. M. Straus, Katia Verhamme, Bruno H. Stricker, Jan Bonhoeffer, Gino Picelli, Carmen Ferrajolo, Carlo Giaquinto, Ron M. C. Herings and Florentia Kaguelidou and has published in prestigious journals such as PLoS ONE, Vaccine and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Sandra de Bie

16 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra de Bie Netherlands	11	79	79	58	43	42	16	271
Jay P. Rho United States	9	71 0.9×	59 0.7×	46 0.8×	67 1.6×	88 2.1×	17	316
Maysa Suyagh Jordan	8	76 1.0×	87 1.1×	41 0.7×	27 0.6×	78 1.9×	22	344
Ratinder Jhaj India	11	45 0.6×	68 0.9×	43 0.7×	42 1.0×	53 1.3×	44	353
Josep Maria Castel Spain	8	59 0.7×	59 0.7×	23 0.4×	49 1.1×	41 1.0×	15	285
Francesco Innocenti Italy	10	103 1.3×	80 1.0×	107 1.8×	69 1.6×	21 0.5×	20	451
Karen Saljé Germany	6	94 1.2×	81 1.0×	17 0.3×	27 0.6×	102 2.4×	7	290
L. Beretz France	7	46 0.6×	30 0.4×	106 1.8×	36 0.8×	104 2.5×	22	343
Ambrose O. Isah Nigeria	11	60 0.8×	123 1.6×	20 0.3×	34 0.8×	82 2.0×	38	322
CB Tripathi India	9	55 0.7×	57 0.7×	33 0.6×	47 1.1×	61 1.5×	22	331
Ahmed Y. Mayet Saudi Arabia	12	64 0.8×	46 0.6×	59 1.0×	38 0.9×	211 5.0×	25	477

Countries citing papers authored by Sandra de Bie

Since Specialization

Citations

This map shows the geographic impact of Sandra de Bie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra de Bie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra de Bie more than expected).

Fields of papers citing papers by Sandra de Bie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra de Bie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra de Bie. The network helps show where Sandra de Bie may publish in the future.

Co-authorship network of co-authors of Sandra de Bie

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra de Bie. A scholar is included among the top collaborators of Sandra de Bie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra de Bie. Sandra de Bie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hek, Karin, Linda E. Flinterman, Ron M. C. Herings, et al.. (2020). Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands. Pharmacoepidemiology and Drug Safety. 29(12). 1659–1668. 9 indexed citations

Bie, Sandra de, Florentia Kaguelidou, Katia Verhamme, et al.. (2016). Using Prescription Patterns in Primary Care to Derive New Quality Indicators for Childhood Community Antibiotic Prescribing. The Pediatric Infectious Disease Journal. 35(12). 1317–1323. 48 indexed citations

Fregonese, Federica, Carmen Ferrajolo, Katia Verhamme, et al.. (2015). Pediatric Drug Safety Signal Detection: A New Drug–Event Reference Set for Performance Testing of Data-Mining Methods and Systems. Drug Safety. 38(2). 207–217. 19 indexed citations

Bie, Sandra de, Carmen Ferrajolo, Sabine M. J. M. Straus, et al.. (2015). Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project. PLoS ONE. 10(6). e0130399–e0130399. 29 indexed citations

Bie, Sandra de, Preciosa M. Coloma, Carmen Ferrajolo, et al.. (2015). The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study. British Journal of Clinical Pharmacology. 80(2). 304–314. 17 indexed citations

Valkhoff, Vera E., Ron M. C. Herings, Marjolein Engelkes, et al.. (2015). Quick assessment of drug-related admissions over time (QUADRAT study). Pharmacoepidemiology and Drug Safety. 24(5). 495–503. 12 indexed citations

Ferrajolo, Carmen, Preciosa M. Coloma, Katia Verhamme, et al.. (2014). Signal Detection of Potentially Drug-Induced Acute Liver Injury in Children Using a Multi-Country Healthcare Database Network. Drug Safety. 37(2). 99–108. 23 indexed citations

Coloma, Preciosa M. & Sandra de Bie. (2014). Data Mining Methods to Detect Sentinel Associations and Their Application to Drug Safety Surveillance. Current Epidemiology Reports. 1(3). 110–119. 1 indexed citations

Ferrajolo, Carmen, Katia Verhamme, Gianluca Trifirò, et al.. (2013). Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries. Drug Safety. 36(10). 1007–1016. 19 indexed citations

10.

Ruiter, Rikje, Loes E. Visser, Myrthe P. P. van Herk‐Sukel, et al.. (2012). Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals. Drug Safety. 35(6). 471–480. 33 indexed citations

11.

Bie, Sandra de, Katia Verhamme, Sabine M. J. M. Straus, Bruno H. Stricker, & Miriam Sturkenboom. (2012). Vaccine-Based Subgroup Analysis in VigiBase. Drug Safety. 35(4). 335–346. 11 indexed citations

12.

Valkhoff, Vera E., Eva M. van Soest, Gwen Masclee, et al.. (2012). Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal ‐ a 617 400‐patient study. Alimentary Pharmacology & Therapeutics. 36(8). 790–799. 11 indexed citations

13.

Bie, Sandra de, et al.. (2011). Safety of pandemic H1N1 vaccines in children and adolescents. Vaccine. 29(43). 7559–7571. 19 indexed citations

14.

Berg, Jochem van den, Sandra de Bie, Folkert J. Meijboom, et al.. (2007). Changes during exercise of ECG intervals related to increased risk for ventricular arrhythmia in repaired tetralogy of Fallot and their relationship to right ventricular size and function. International Journal of Cardiology. 124(3). 332–338. 9 indexed citations

15.

Paepe, A. De & Sandra de Bie. (1991). Genetic counseling of a couple presenting respectively terminal transverse defects and congenital arthrogryposis.. PubMed. 2(4). 195–203. 2 indexed citations

16.

Thiery, M, et al.. (1974). Cytogenetic evaluation of patients in relation to the use of oral contraception. Contraception. 10(1). 25–38. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact